Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Commitment Safety Study of HZ/su to Evaluate Pregnancy Exposures and Outcomes in Immunodeficient or Immunosuppressed Women Between 18 and 49 Years of Age

NCT05811754 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT05811754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Commitment Safety Study of HZ/su to Evaluate Pregnancy Exposures and Outcomes in Immunodeficient or Immunosuppressed Women Between 18 and 49 Years of Age
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Active, not recruiting
Start date
May 9, 2022
Completion date
March 31, 2028
Enrollment
2,844 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster